sb 203580 has been researched along with Diabetes Mellitus, Type 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichijo, H; Kadowaki, H; Namba, Y; Nishitoh, H; Ouchi, Y; Takeda, K; Ueda, I; Yamaguchi, K | 1 |
| Jiang, JD; Kong, WJ; Li, ZR; Pan, HN; Shan, N; Si, SY; Song, DQ; Wang, YM; Wei, J; Xue, R; Yang, P; You, XF; Zhang, H; Zhao, LX; Zhao, W; Zhou, ZX | 1 |
| Becker, TC; Cao, W; Collins, QF; Collins, S; Daniel, KW; Floering, L; Lupo, EG; Robidoux, J; Xiong, Y | 1 |
3 other study(ies) available for sb 203580 and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Involvement of ASK1-p38 pathway in the pathogenesis of diabetes triggered by pancreatic ß cell exhaustion.
Topics: Amino Acid Substitution; Animals; Cell Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Humans; Imidazoles; Insulin; Insulin-Secreting Cells; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Mice; Mice, Knockout; Mutation, Missense; p38 Mitogen-Activated Protein Kinases; Pyridines | 2013 |
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Topics: Animals; Berberine; Cell Line, Tumor; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Mice; Mice, Inbred NOD; Protein Kinase C; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Up-Regulation | 2009 |
p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.
Topics: Acetylcysteine; Adenoviridae; Animals; Cell Line, Tumor; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Inhibitors; Gene Silencing; Glucagon; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Hepatocytes; Imidazoles; Liver; Mice; p38 Mitogen-Activated Protein Kinases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Promoter Regions, Genetic; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Streptozocin; Trans-Activators; Transcription Factors; Transfection | 2005 |